{"id":"W2023017226","doi":"10.3899/jrheum.130637","title":"One-year Efficacy and Safety Results of Secukinumab in Patients With Rheumatoid Arthritis: Phase II, Dose-finding, Double-blind, Randomized, Placebo-controlled Study","year":2014,"lang":"en","type":"article","venue":"The Journal of Rheumatology","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Secukinumab; Rheumatoid arthritis; Placebo; Double blind; Randomized controlled trial; Placebo-controlled study; Internal medicine; Dermatology; Surgery; Alternative medicine; Pathology; Psoriatic arthritis","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002829327,0.001472106,0.002705455,0.0003975182,0.0004729292,0.0008297525,0.0007264952,0.001745922,0.003960686],"category_scores_gemma":[0.001704465,0.0006129497,0.001549011,0.0003447689,0.000820476,0.0008271572,0.0003000062,0.001996468,0.0008578811],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004161232,"about_ca_system_score_gemma":0.000749057,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002797737,"about_ca_topic_score_gemma":0.0005379987,"domain_scores_codex":[0.9991727,0.0003732284,0.00008841817,0.0001530269,0.00009975425,0.000112899],"domain_scores_gemma":[0.9985029,0.000327284,0.0004676459,0.0001286259,0.0001364948,0.0004370582],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9305105,0.02473004,0.003343987,0.0007446082,0.001242764,0.00008287361,0.00007925062,0.0004237021,0.01160691,0.00004020836,0.0007204976,0.0264746],"study_design_scores_gemma":[0.736454,0.2492574,0.01109169,0.0000321008,0.0006094233,0.00008341925,0.00002125146,0.0003625313,0.001384958,0.00004568025,0.000633201,0.00002438907],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9935467,0.003116688,0.0004880287,0.0001693464,0.0001360809,0.001234253,0.0005538139,0.00008468868,0.0006704332],"genre_scores_gemma":[0.9906687,0.002208114,0.0009158814,0.0008582729,0.0003429716,0.00202864,0.001192803,0.00001918287,0.001765467],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003960686,"threshold_uncertainty_score":0.01496309,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01475950531476425,"score_gpt":0.2850734577669825,"score_spread":0.2703139524522182,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}